Trial record 1 of 1 for: nct01094691
Previous Study | Return to List | Next Study
Haufen Diagnostic Biomarkers of BK Renal Disease
This study is enrolling participants by invitation only.
University of North Carolina, Chapel Hill
First Posted: March 29, 2010
Last Update Posted: April 19, 2017
Astellas Pharma US, Inc.
Information provided by (Responsible Party):
Volker Nickeleit, MD, University of North Carolina, Chapel Hill
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is enrolling participants by invitation only.|
|Estimated Study Completion Date:||December 2019|
|Estimated Primary Completion Date:||July 2019 (Final data collection date for primary outcome measure)|